Growth retardation in premenarchial female rhesus monkeys during chronic administration of a GnRH agonist (leuprolide acetate)

Mari S. Golub, Dennis M Styne, Mark D. Wheeler, Carl L Keen, Andrew G Hendrickx, Fernando Moran, M. Eric Gershwin

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Leuprolide acetate in depot form (0.75 mg/kg body weight/month, im) was administered to four female rhesus monkeys from 18-30 months of age, a period that includes the premenarchial growth spurt. They were compared to eight age matched controls. As anticipated, sexual maturation was blocked in the Leuprolide group and menarche did not occur. Growth was also severely retarded; no weight gain occurred during the study in the Leuprolide group as compared to a 25% weight gain (P = .004) in the control group. The Leuprolide group also lost muscle mass. Food intake normalized for body weight was not affected. Linear growth averaged 35% less in the Leuprolide group. Serum IGF-1 concentrations increased from 486±84 to 965±47 ng/mL (P = .0025) in the Leuprolide group and from 838±139 to 3,006±545 ng/mL (P = .0016) in the control group. These data suggest that premenarchial pituitary/gonadal suppression results in a distinctive pattern of growth retardation in monkeys.

Original languageEnglish (US)
Pages (from-to)248-256
Number of pages9
JournalJournal of Medical Primatology
Volume26
Issue number5
StatePublished - 1997

Fingerprint

Leuprolide
Macaca mulatta
Gonadotropin-Releasing Hormone
growth retardation
agonists
acetates
weight gain
menarche
body weight
Growth
monkeys
food intake
muscles
Weight Gain
Body Weight
Sexual Maturation
Control Groups
Menarche
Insulin-Like Growth Factor I
Haplorhini

Keywords

  • Adolescence
  • Body composition
  • Growth spurt
  • Long bones
  • Menarche
  • Puberty

ASJC Scopus subject areas

  • Animal Science and Zoology
  • veterinary(all)

Cite this

Growth retardation in premenarchial female rhesus monkeys during chronic administration of a GnRH agonist (leuprolide acetate). / Golub, Mari S.; Styne, Dennis M; Wheeler, Mark D.; Keen, Carl L; Hendrickx, Andrew G; Moran, Fernando; Gershwin, M. Eric.

In: Journal of Medical Primatology, Vol. 26, No. 5, 1997, p. 248-256.

Research output: Contribution to journalArticle

Golub, Mari S. ; Styne, Dennis M ; Wheeler, Mark D. ; Keen, Carl L ; Hendrickx, Andrew G ; Moran, Fernando ; Gershwin, M. Eric. / Growth retardation in premenarchial female rhesus monkeys during chronic administration of a GnRH agonist (leuprolide acetate). In: Journal of Medical Primatology. 1997 ; Vol. 26, No. 5. pp. 248-256.
@article{23132ecfd2af4389bb4320901cccd630,
title = "Growth retardation in premenarchial female rhesus monkeys during chronic administration of a GnRH agonist (leuprolide acetate)",
abstract = "Leuprolide acetate in depot form (0.75 mg/kg body weight/month, im) was administered to four female rhesus monkeys from 18-30 months of age, a period that includes the premenarchial growth spurt. They were compared to eight age matched controls. As anticipated, sexual maturation was blocked in the Leuprolide group and menarche did not occur. Growth was also severely retarded; no weight gain occurred during the study in the Leuprolide group as compared to a 25{\%} weight gain (P = .004) in the control group. The Leuprolide group also lost muscle mass. Food intake normalized for body weight was not affected. Linear growth averaged 35{\%} less in the Leuprolide group. Serum IGF-1 concentrations increased from 486±84 to 965±47 ng/mL (P = .0025) in the Leuprolide group and from 838±139 to 3,006±545 ng/mL (P = .0016) in the control group. These data suggest that premenarchial pituitary/gonadal suppression results in a distinctive pattern of growth retardation in monkeys.",
keywords = "Adolescence, Body composition, Growth spurt, Long bones, Menarche, Puberty",
author = "Golub, {Mari S.} and Styne, {Dennis M} and Wheeler, {Mark D.} and Keen, {Carl L} and Hendrickx, {Andrew G} and Fernando Moran and Gershwin, {M. Eric}",
year = "1997",
language = "English (US)",
volume = "26",
pages = "248--256",
journal = "Journal of Medical Primatology",
issn = "0047-2565",
publisher = "Blackwell Munksgaard",
number = "5",

}

TY - JOUR

T1 - Growth retardation in premenarchial female rhesus monkeys during chronic administration of a GnRH agonist (leuprolide acetate)

AU - Golub, Mari S.

AU - Styne, Dennis M

AU - Wheeler, Mark D.

AU - Keen, Carl L

AU - Hendrickx, Andrew G

AU - Moran, Fernando

AU - Gershwin, M. Eric

PY - 1997

Y1 - 1997

N2 - Leuprolide acetate in depot form (0.75 mg/kg body weight/month, im) was administered to four female rhesus monkeys from 18-30 months of age, a period that includes the premenarchial growth spurt. They were compared to eight age matched controls. As anticipated, sexual maturation was blocked in the Leuprolide group and menarche did not occur. Growth was also severely retarded; no weight gain occurred during the study in the Leuprolide group as compared to a 25% weight gain (P = .004) in the control group. The Leuprolide group also lost muscle mass. Food intake normalized for body weight was not affected. Linear growth averaged 35% less in the Leuprolide group. Serum IGF-1 concentrations increased from 486±84 to 965±47 ng/mL (P = .0025) in the Leuprolide group and from 838±139 to 3,006±545 ng/mL (P = .0016) in the control group. These data suggest that premenarchial pituitary/gonadal suppression results in a distinctive pattern of growth retardation in monkeys.

AB - Leuprolide acetate in depot form (0.75 mg/kg body weight/month, im) was administered to four female rhesus monkeys from 18-30 months of age, a period that includes the premenarchial growth spurt. They were compared to eight age matched controls. As anticipated, sexual maturation was blocked in the Leuprolide group and menarche did not occur. Growth was also severely retarded; no weight gain occurred during the study in the Leuprolide group as compared to a 25% weight gain (P = .004) in the control group. The Leuprolide group also lost muscle mass. Food intake normalized for body weight was not affected. Linear growth averaged 35% less in the Leuprolide group. Serum IGF-1 concentrations increased from 486±84 to 965±47 ng/mL (P = .0025) in the Leuprolide group and from 838±139 to 3,006±545 ng/mL (P = .0016) in the control group. These data suggest that premenarchial pituitary/gonadal suppression results in a distinctive pattern of growth retardation in monkeys.

KW - Adolescence

KW - Body composition

KW - Growth spurt

KW - Long bones

KW - Menarche

KW - Puberty

UR - http://www.scopus.com/inward/record.url?scp=0031242315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031242315&partnerID=8YFLogxK

M3 - Article

C2 - 9437263

AN - SCOPUS:0031242315

VL - 26

SP - 248

EP - 256

JO - Journal of Medical Primatology

JF - Journal of Medical Primatology

SN - 0047-2565

IS - 5

ER -